Tiedemann Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$3.82M Buy
25,535
+6,951
+37% +$1.04M 0.16% 55
2023
Q2
$2.5M Buy
18,584
+3,813
+26% +$514K 0.11% 70
2023
Q1
$2.35M Buy
14,771
+3,981
+37% +$634K 0.11% 72
2022
Q4
$1.74M Buy
10,790
+568
+6% +$91.8K 0.08% 83
2022
Q3
$1.37M Sell
10,222
-424
-4% -$56.9K 0.08% 94
2022
Q2
$1.63M Sell
10,646
-2,654
-20% -$406K 0.12% 82
2022
Q1
$2.16M Sell
13,300
-1,409
-10% -$229K 0.11% 85
2021
Q4
$1.99M Sell
14,709
-301
-2% -$40.8K 0.1% 90
2021
Q3
$1.62M Sell
15,010
-6,059
-29% -$652K 0.09% 98
2021
Q2
$2.38M Sell
21,069
-511
-2% -$57.6K 0.1% 98
2021
Q1
$2.34M Sell
21,580
-396
-2% -$42.8K 0.1% 95
2020
Q4
$2.35M Sell
21,976
-1,235
-5% -$132K 0.11% 91
2020
Q3
$2.03M Buy
23,211
+318
+1% +$27.9K 0.1% 124
2020
Q2
$2.25M Sell
22,893
-1,091
-5% -$107K 0.12% 109
2020
Q1
$1.83M Sell
23,984
-1,405
-6% -$107K 0.12% 104
2019
Q4
$2.25M Buy
25,389
+9,227
+57% +$818K 0.11% 108
2019
Q3
$1.23M Buy
16,162
+4,333
+37% +$329K 0.06% 154
2019
Q2
$861K Sell
11,829
-1,669
-12% -$121K 0.04% 165
2019
Q1
$1.09M Sell
13,498
-899
-6% -$72.3K 0.05% 210
2018
Q4
$1.33M Buy
14,397
+1,957
+16% +$181K 0.07% 172
2018
Q3
$1.18M Buy
12,440
+2,150
+21% +$203K 0.07% 155
2018
Q2
$955K Buy
10,290
+3,211
+45% +$298K 0.06% 167
2018
Q1
$669K Buy
7,079
+16
+0.2% +$1.51K 0.05% 175
2017
Q4
$683K Sell
7,063
-3,154
-31% -$305K 0.05% 138
2017
Q3
$766K Sell
10,217
-11,664
-53% -$874K 0.07% 171
2017
Q2
$1.59M Buy
21,881
+1,302
+6% +$94.4K 0.12% 144
2017
Q1
$1.34M Buy
20,579
+3,002
+17% +$196K 0.11% 150
2016
Q4
$1.1M Buy
17,577
+8,308
+90% +$520K 0.11% 136
2016
Q3
$572K Buy
+9,269
New +$572K 0.12% 88